Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

1.

Medicaid payment mechanisms: impact on medication adherence and health care service utilization in type 2 diabetes enrollees.

Pawaskar M, Burch S, Seiber E, Nahata M, Iaconi A, Balkrishnan R.

Popul Health Manag. 2010 Aug;13(4):209-18. doi: 10.1089/pop.2009.0046.

PMID:
20455787
[PubMed - indexed for MEDLINE]
2.

Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.

Pawaskar MD, Camacho FT, Anderson RT, Cobden D, Joshi AV, Balkrishnan R.

Clin Ther. 2007;29 Spec No:1294-305.

PMID:
18046929
[PubMed - indexed for MEDLINE]
3.

Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.

Pawaskar MD, Camacho FT, Anderson RT, Cobden D, Joshi AV, Balkrishnan R.

Clin Ther. 2007 Jun;29(6 Pt 1):1294-305.

PMID:
18036391
[PubMed - indexed for MEDLINE]
4.

Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in medicaid-enrolled patients with type 2 diabetes mellitus.

Balkrishnan R, Arondekar BV, Camacho FT, Shenolikar RA, Horblyuk R, Anderson RT.

Clin Ther. 2007;29 Spec No:1306-15.

PMID:
18046930
[PubMed - indexed for MEDLINE]
5.

Outcomes associated with introduction of thiazolidinedione therapy in Medicaid enrolled patients with type 2 diabetes: an updated and expanded retrospective analysis.

Balkrishnan R, Rajagopalan R, Shenolikar RA, Camacho FT, Anderson RT.

Curr Med Res Opin. 2006 Mar;22(3):551-9.

PMID:
16574038
[PubMed - indexed for MEDLINE]
6.

Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study.

Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT.

Clin Ther. 2003 Nov;25(11):2958-71.

PMID:
14693318
[PubMed - indexed for MEDLINE]
7.

Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.

Balkrishnan R, Arondekar BV, Camacho FT, Shenolikar RA, Horblyuk R, Anderson RT.

Clin Ther. 2007 Jun;29(6 Pt 1):1306-15.

PMID:
18036392
[PubMed - indexed for MEDLINE]
8.

Variation in outpatient mental health service utilization under capitation.

Chou AF, Wallace N, Bloom JR, Hu TW.

J Ment Health Policy Econ. 2005 Mar;8(1):3-14.

PMID:
15870481
[PubMed - indexed for MEDLINE]
9.

Healthcare costs and prescription adherence with introduction of thiazolidinedione therapy in Medicaid type 2 diabetic patients: a retrospective data analysis.

Balkrishnan R, Rajagopalan R, Shenolikar RA, Camacho FT, Whitmire JT, Anderson RT.

Curr Med Res Opin. 2004 Oct;20(10):1633-40. Erratum in: Curr Med Res Opin. 2005 Feb;21(2):323.

PMID:
15462696
[PubMed - indexed for MEDLINE]
10.

Health care utilization by children with chronic illnesses: a comparison of medicaid and employer-insured managed care.

Shatin D, Levin R, Ireys HT, Haller V.

Pediatrics. 1998 Oct;102(4):E44.

PMID:
9755281
[PubMed - indexed for MEDLINE]
11.
12.

Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.

Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL.

Clin Ther. 2006 Oct;28(10):1712-25; discussion 1710-1. Erratum in: Clin Ther. 2006 Nov;28(11):1968-9.

PMID:
17157128
[PubMed - indexed for MEDLINE]
13.

Improvements in diabetes management and outcomes in a Medicaid managed care system.

Bailey JE, Womeodu RJ, Wan JY, Van Brunt DL, Somes GW.

Tenn Med. 2001 Nov;94(11):425-30.

PMID:
11709896
[PubMed - indexed for MEDLINE]
14.

Medical utilization and costs associated with statin adherence in Medicaid enrollees with type 2 diabetes.

Wu J, Seiber E, Lacombe VA, Nahata MC, Balkrishnan R.

Ann Pharmacother. 2011 Mar;45(3):342-9. doi: 10.1345/aph.1P539. Epub 2011 Feb 15.

PMID:
21325098
[PubMed - indexed for MEDLINE]
15.

Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.

Hartung DM, Carlson MJ, Kraemer DF, Haxby DG, Ketchum KL, Greenlick MR.

Med Care. 2008 Jun;46(6):565-72. doi: 10.1097/MLR.0b013e3181734a77.

PMID:
18520310
[PubMed - indexed for MEDLINE]
16.
17.

Race and medication adherence in Medicaid enrollees with type-2 diabetes.

Shenolikar RA, Balkrishnan R, Camacho FT, Whitmire JT, Anderson RT.

J Natl Med Assoc. 2006 Jul;98(7):1071-7.

PMID:
16895275
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Impact of medication adherence on hospitalization risk and healthcare cost.

Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS.

Med Care. 2005 Jun;43(6):521-30.

PMID:
15908846
[PubMed - indexed for MEDLINE]
19.

A comparison by payor/provider type of the cost of dying among frail older adults.

Experton B, Ozminkowski RJ, Branch LG, Li Z.

J Am Geriatr Soc. 1996 Sep;44(9):1098-107.

PMID:
8790240
[PubMed - indexed for MEDLINE]
20.

Medical costs of managed care in patients with type 2 diabetes mellitus.

Bhattacharyya SK, Else BA.

Clin Ther. 1999 Dec;21(12):2131-42.

PMID:
10645758
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk